Milestone
3.4.b
Information needs guidance
Not started
High priority
Develop a set of principles to inform regulatory evaluation of broadly protective coronavirus vaccines that outlines what information is required to demonstrate the need for and added value of variant-proof SARS-CoV-2 vaccines and to provide confidence in vaccine efficacy, particularly compared to approved vaccines.